Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Apremilast for Atopic Dermatitis

This study has been completed.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT01393158
First received: July 12, 2011
Last updated: NA
Last verified: April 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given